Computational Virtual Screening Towards Designing Novel Anticancer Drugs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 208
Special Issue Editor
Interests: biophysics; chemical engineering; biomedical engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Virtual Screening is a very useful tool to predict the drug affinities and drug actions according to the receptors' structural and functional aspects of molecules, towards the interpretation of biochemical mechanisms and the identification of novel functional compounds.
Several approaches have been developed over recent decades, and many applications are reported in the literature. The most recent years have been characterized by the availability of large data sets, and the drug design is more powerful during the more precise protein structures, as demonstrated by the Cryo-Electron Microscopy Facility.
This Special Issue will include research articles that describe the development of novel virtual screening approaches and the applications of current methods to unexplained aspects of biophysical phenomena, with the opportunity to present purely computational studies, such as Alfafold methodology, to predict precisely novel anticancer drugs.
Prof. Dr. Po-Yuan Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- structure biology
- anticancer drugs
- artificial intelligence
- cryo-electron microscopy
- precision medicine
- Alfafold
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
